The novel sweetener aspartame was discovered in the United States in 1965 (Romanovski, 2009). James Schlatter, a chemist and a medical researcher, working for G.D. Searle and Co., was developing a new anti-ulcer treatment. One of the possibilities was to find an inhibitor of the gastrointestinal secretory hormone gastrin. Because the drug discovery at that time was a trial-and-error method, Schlatter had to synthesise C-terminal tetrapeptide (Trp-Met-Asp-Phe-NH2), usually found in the stomach, in